The Global Resource For Connecting Buyers and Sellers

Frost & Sullivan Publishes Update Coverage Report on BiolineRx Ltd.: Continued advancement and execution of BiolineRx’s lead oncology project – BL-8040; sufficient funds to support clinical strategy; stock target price remains at NIS 5.15

TEL AVIV, Israel, March 26, 2018 /PRNewswire/ — TASE analysis project was launched in 2016 in order to raise the investors’ level of knowledge of TASE listed technology and life-science companies and the markets in which the companies operate, thus creating appropriate pricing and…